https://sputnikglobe.com/20211029/rdif-hails-eus-decision-to-open-borders-for-sputnik-v-vaccinated-visitors-from-argentina-1090325457.html
RDIF Hails EU's Decision to Open Borders for Sputnik V Vaccinated Visitors From Argentina
RDIF Hails EU's Decision to Open Borders for Sputnik V Vaccinated Visitors From Argentina
Sputnik International
Argentina was the first Latin American country both to approve the use of the Sputnik V vaccine against coronavirus and to localise production. 29.10.2021, Sputnik International
2021-10-29T18:59+0000
2021-10-29T18:59+0000
2023-04-12T17:14+0000
argentina
europe
vaccine
covid-19
sputnik v vaccine
european union (eu)
https://cdn1.img.sputnikglobe.com/img/07e5/0a/1d/1090325210_0:89:3073:1817_1920x0_80_0_0_6b2923ffe45e9b090f2a67df7a9b3aa4.jpg
The Russian Direct Investment Fund (RDIF) has hailed a European Council recommendation to EU countries to lift travel restrictions imposed on Argentina, the only manufacturer of the Russian Sputnik V vaccine in South America. In a 29 October press release, Russia's sovereign wealth fund, which is responsible for marketing Sputnik V overseas, called the Council's suggestion a testimony to the success of the vaccination campaign in Argentina. The Argentine Ministry of Health has previously published a study, which showed that Sputnik V offered a greater immune protection than other vaccines used in the country. A different study conducted by the National University of Córdoba demonstrated that the Russian-made vaccine was more effective against the Delta strain of coronavirus than AstraZeneca and Sinopharm jabs. RDIF, for its part, has emphasised that Argentina has witnessed a thirtyfold decrease in the daily COVID-19 caseload over the past five months thanks to a successful vaccination campaign. Aside from Argentina, the European Council has advised to remove travel restrictions for Chile, the United Arab Emirates, Bahrain, and Jordan. All these countries have approved Sputnik V for use.Argentina was the first Latin American country to authorise the Russian vaccine for use. Later, it announced plans to produce 4-5 million doses of Sputnik V monthly and expects to ramp up yearly production to 500 million doses. Sputnik V, the world's first vaccine against the coronavirus, has been approved in 70 countries so far. Since early March, Sputnik V has been under review by the European Medicines Agency (EMA).
argentina
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
argentina, europe, vaccine, covid-19, sputnik v vaccine, european union (eu)
argentina, europe, vaccine, covid-19, sputnik v vaccine, european union (eu)
RDIF Hails EU's Decision to Open Borders for Sputnik V Vaccinated Visitors From Argentina
18:59 GMT 29.10.2021 (Updated: 17:14 GMT 12.04.2023) Argentina was the first Latin American country both to approve the use of the Sputnik V vaccine against coronavirus and to localise production.
The Russian Direct Investment Fund (RDIF) has hailed a European Council recommendation to EU countries to lift travel restrictions imposed on Argentina,
the only manufacturer of the Russian Sputnik V vaccine in South America.
In a 29 October press release, Russia's sovereign wealth fund, which is responsible for marketing Sputnik V overseas, called the Council's suggestion a testimony to the success of the vaccination campaign in Argentina.
The Argentine Ministry of Health has previously published a study, which showed that Sputnik V offered a greater immune protection than other vaccines used in the country. A different study conducted by the National University of Córdoba demonstrated that the Russian-made vaccine was more effective against the Delta strain of coronavirus than AstraZeneca and Sinopharm jabs.
RDIF, for its part, has emphasised that Argentina has witnessed a thirtyfold decrease in the daily COVID-19 caseload over the past five months thanks to a successful vaccination campaign.
"Sputnik V has played a decisive role in protecting the population of Argentina and helping the country to stay among the leaders in the fight against coronavirus", the wealth fund said in the press release.
Aside from Argentina, the European Council has advised to remove travel restrictions for Chile, the United Arab Emirates, Bahrain, and Jordan. All these countries have approved Sputnik V for use.
Argentina was the first Latin American country to authorise the Russian vaccine for use. Later, it
announced plans to produce 4-5 million doses of Sputnik V monthly and expects to ramp up yearly production to 500 million doses.
Sputnik V, the world's first vaccine against the coronavirus, has been approved in 70 countries so far. Since early March, Sputnik V has been under review by the European Medicines Agency (EMA).
